Explores mobile-native governance for agentic AI, reducing deployment errors in applications, suggesting structural improvements.
Consumer mobile platforms now constitute the primary delivery channel for agentic AI, with global app releases surging 60-104% year-over-year in 2026, driven by AI-assisted development tools. Yet existing agentic governance frameworks, designed for mutable server-side enterprise deployments, cannot address the structural constraints unique to mobile: binary immutability, platform gatekeeper non-determinism, consumer-scale blast radius, ambient agent surface expansion, and regulatory exposure. We present MobileGuard, the first mobile-native governance framework for agentic AI, operationalizing four pillars across the mobile SDLC: Pre-Deployment Quality Contracts (PDQC), Tiered Autonomy Calibration for Mobile (TAC-M), Platform Gatekeeper Simulation and Governance (PGSG), and Ambient Agent Boundary Enforcement (AABE). MobileGuard is validated through three empirical studies. Study 1 presents a governance failure taxonomy derived from 2,847 real-world iOS and Android platform rejection records, identifying 23 failure categories across 6 pillars with 71.3% of failures undetectable by existing frameworks. Study 2 demonstrates a 74.1% Deployment Error Rate reduction (p less than 0.001) against a production mobile SDLC pipeline across three applications, outperforming AGENTSAFE by 45.7 percentage points. Study 3 presents a real-world cross-sectional audit of 942 mobile platform applications (iOS-primary; Android replication in progress) using AS-009, a novel release notes AI disclosure scanner covering both App Store and Google Play governance signals, finding a 4.0% governance signal rate with externally-derived violations observed in enterprise-scale developers including Adobe Inc. and Moleskine Srl, resolving the author-defined scenario circularity concern from Study 2. MobileGuard maps to ISO 42001:2023 and the EU AI Act, and is implemented as an open-source CLI available at github.com/jsingh6/mobileguard.
No takes yet. Share an insight, caveat, or question.
Jaspreet Singh (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: